New York, New York (PRWEB) November 20, 2013
Product liability claims filed in the wake of the 2012 Stryker hip recall (http://www.strykerhiprecallclaims.com/) for Rejuvenate and ABG II Modular-Neck Hip Stems continue to mount in courts throughout the country, Bernstein Liebhard LLP reports. According to a new case list issued by the Court on November 18, 2013, 553 Stryker hip lawsuits have been filed in a multicounty litigation underway in New Jersey’s Bergen County Superior Court on behalf individuals who were allegedly injured by Rejuvenate and ABG II hip stems. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“We are representing a number of Stryker lawsuit clients in this proceeding, and continue to hear from alleged victims of Rejuvenate and ABG II hip stems on a regular basis. It’s not surprising that the number of filings have surpassed 550,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have suffered serious complications, allegedly related to the Stryker recall for Rejuvenate and ABG II hip stems.
Stryker Hip Recall
Stryker announced the Rejuvenate and ABG II hip stem recall in July 2012, after post-market data indicated the metal components were vulnerable to a high rate of fretting and corrosion at the modular neck junction, placing recipients at risk for pain, swelling, adverse local tissue reactions, and premature failure of their hip implant. Stryker has advised all Rejuvenate and ABG II patients to undergo imaging and blood tests to ensure their hips are functioning properly, even if they are not experiencing any symptoms that would indicate otherwise. According to the Stryker recall notice, some Rejuvenate and ABG II recipients who presented without symptoms have nevertheless suffered adverse local tissue reactions and elevated levels of metal ions in their blood.*
Since the recall was announced, court documents indicate that hundreds of Rejuvenate and ABG II patients have filed Stryker lawsuits seeking compensation for injuries allegedly caused by the devices. In addition to the cases pending in New Jersey State Court, court documents show that at least 395 Stryker recall claims have been filed in a federal multidistrict litigation underway in U.S. District Court, District of Minnesota.( In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441) All of the lawsuits involve similar allegations involving the propensity of the Rejuvenate and ABG II components to shed dangerous amounts of metal ions into recipients’ tissue and blood stream, which the complaints claim can cause metallosis, adverse local tissue reactions, necrosis, osteolysis, and failure of the hip.
Individuals who have allegedly suffered complications as a result of Rejuvenate and ABG II hip stems may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. For more information on the Stryker hip recall, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP